Abstract:Colorectal cancer (CRC) remains the leading cause of cancer-related death in the world. Aspirin (ASA) and curcumin (CUR) are widely investigated chemopreventive candidates for CRC. However, the precise mechanisms of their action and their combinatorial effects have not been evaluated. The purpose of the present study was to determine the effect of ASA, CUR, and their combination in azoxymethane/dextran sulfate sodium (AOM/DSS)-induced colitis-accelerated colorectal cancer (CAC). We also aimed to characterize the differential gene expression profiles in AOM/DSS-induced tumors as well as in tumors modulated by ASA and CUR using RNA-seq. Diets supplemented with 0.02% ASA, 2% CUR or 0.01% ASA+1% CUR were given to mice from 1week prior to the AOM injection until the experiment was terminated 22weeks after AOM initiation. Our results showed that CUR had a superior inhibitory effect in colon tumorigenesis compared to that of ASA. The combination of ASA and CUR at a lower dose exhibited similar efficacy to that of a higher dose of CUR at 2%. RNA isolated from colonic tissue from the control group and from tumor samples from the experimental groups was subjected to RNA-seq. Transcriptomic analysis suggested that the low-dose combination of ASA and CUR modulated larger gene sets than the single treatment. These differentially expressed genes were situated in several canonical pathways important in the inflammatory network and liver metastasis in CAC. We identified a small subset of genes as potential molecular targets involved in the preventive action of the combination of ASA and CUR. Taken together, the current results provide the first evidence in support of the chemopreventive effect of a low-dose combination of ASA and CUR in CAC. Moreover, the transcriptional profile obtained in our study may provide a framework for identifying the mechanisms underlying the carcinogenesis process from normal colonic tissue to tumor development as well as the cancer inhibitory effects and potential molecular targets of ASA and CUR.

[Risk factors and chemoprophylaxis of ulcerative colitis-colorectal cancer].

Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention

An Overview of Molecular Profiles in Ulcerative Colitis–Related Cancer

A Review of Compounds for Prevention of Colorectal Cancer

Prevalence of colorectal cancer in patients with ulcerative colitis: A retrospective, monocenter study in China

Risk of Ulcerative Colitis-Associated Colorectal Cancer in China: A Multi-Center Retrospective Study

[Ulcerative colitis-associated carcinogenesis : An update]

Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease

The risk of colorectal cancer in patients with ulcerative colitis

Colorectal cancer in ulcerative colitis (review)

[Analysis on clinical features of patients with ulcerative colitis associated colorectal cancer].

Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation

Colorectal Dysplasia and Cancer Surveillance in Ulcerative Colitis

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

Exploring the relationship between ulcerative colitis, colorectal cancer, and prostate cancer

The Protection of Crocin Against Ulcerative Colitis and Colorectal Cancer via Suppression of NF-κB-Mediated Inflammation

Clinical and Endoscopic Manifestation of Ulcerative Clitis Associated Colorectal Cancer

Chemoprophylaxis of precancerous lesions in patients who are at a high risk of developing colorectal cancer (Review)

Chinese herbal medicines for prevention and treatment of colorectal cancer: From molecular mechanisms to potential clinical applications

Mechanisms of colitis-accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA-seq

Ulcerative colitis and colon cancer: Biology and surveillance